nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Topoisomerase Inhibitors—Topotecan—cervical cancer	0.559	1	CiPCiCtD
Doxorubicin—uterine cancer—cervical cancer	0.168	0.558	CtDrD
Doxorubicin—ovarian cancer—cervical cancer	0.134	0.442	CtDrD
Doxorubicin—ABCG2—Topotecan—cervical cancer	0.0414	0.634	CbGbCtD
Doxorubicin—ABCB1—Topotecan—cervical cancer	0.0149	0.229	CbGbCtD
Doxorubicin—CYP3A4—Topotecan—cervical cancer	0.00894	0.137	CbGbCtD
Doxorubicin—Metastatic neoplasm—Topotecan—cervical cancer	0.00173	0.081	CcSEcCtD
Doxorubicin—Acute leukaemia—Topotecan—cervical cancer	0.00116	0.0543	CcSEcCtD
Doxorubicin—AURKA—Irinotecan—Topotecan—cervical cancer	0.000917	0.724	CbGdCrCtD
Doxorubicin—Bullous eruption—Topotecan—cervical cancer	0.000837	0.0393	CcSEcCtD
Doxorubicin—Myelosuppression—Topotecan—cervical cancer	0.000706	0.0331	CcSEcCtD
Doxorubicin—SLC22A16—renal system—cervical cancer	0.000679	0.0167	CbGeAlD
Doxorubicin—Mucosal inflammation—Topotecan—cervical cancer	0.000598	0.0281	CcSEcCtD
Doxorubicin—Febrile neutropenia—Topotecan—cervical cancer	0.00055	0.0258	CcSEcCtD
Doxorubicin—Pelvic pain—Topotecan—cervical cancer	0.000544	0.0255	CcSEcCtD
Doxorubicin—SLC22A16—female reproductive system—cervical cancer	0.000544	0.0134	CbGeAlD
Doxorubicin—CBR3—uterine cervix—cervical cancer	0.000543	0.0134	CbGeAlD
Doxorubicin—ABCB8—decidua—cervical cancer	0.000538	0.0132	CbGeAlD
Doxorubicin—ABCB8—renal system—cervical cancer	0.000528	0.013	CbGeAlD
Doxorubicin—CBR3—decidua—cervical cancer	0.000518	0.0127	CbGeAlD
Doxorubicin—CBR3—endometrium—cervical cancer	0.000492	0.0121	CbGeAlD
Doxorubicin—Neuralgia—Topotecan—cervical cancer	0.000476	0.0224	CcSEcCtD
Doxorubicin—CBR3—mammalian vulva—cervical cancer	0.000475	0.0117	CbGeAlD
Doxorubicin—Lung disorder—Topotecan—cervical cancer	0.000468	0.0219	CcSEcCtD
Doxorubicin—Rash erythematous—Topotecan—cervical cancer	0.000432	0.0203	CcSEcCtD
Doxorubicin—Pleural effusion—Topotecan—cervical cancer	0.000432	0.0203	CcSEcCtD
Doxorubicin—ABCB8—female reproductive system—cervical cancer	0.000423	0.0104	CbGeAlD
Doxorubicin—AKR1A1—uterine cervix—cervical cancer	0.00042	0.0103	CbGeAlD
Doxorubicin—CBR3—female reproductive system—cervical cancer	0.000407	0.01	CbGeAlD
Doxorubicin—Rigors—Topotecan—cervical cancer	0.000405	0.019	CcSEcCtD
Doxorubicin—AKR1A1—decidua—cervical cancer	0.0004	0.00982	CbGeAlD
Doxorubicin—AKR1A1—renal system—cervical cancer	0.000393	0.00965	CbGeAlD
Doxorubicin—ABCB8—female gonad—cervical cancer	0.000385	0.00946	CbGeAlD
Doxorubicin—NDUFS7—uterine cervix—cervical cancer	0.000381	0.00937	CbGeAlD
Doxorubicin—AKR1A1—endometrium—cervical cancer	0.00038	0.00933	CbGeAlD
Doxorubicin—Extravasation—Topotecan—cervical cancer	0.000379	0.0178	CcSEcCtD
Doxorubicin—CBR3—female gonad—cervical cancer	0.000371	0.00911	CbGeAlD
Doxorubicin—CBR3—vagina—cervical cancer	0.000368	0.00905	CbGeAlD
Doxorubicin—AKR1A1—mammalian vulva—cervical cancer	0.000367	0.00902	CbGeAlD
Doxorubicin—Hyperbilirubinaemia—Topotecan—cervical cancer	0.000364	0.0171	CcSEcCtD
Doxorubicin—NDUFS7—renal system—cervical cancer	0.000357	0.00877	CbGeAlD
Doxorubicin—AURKA—uterine cervix—cervical cancer	0.000355	0.00871	CbGeAlD
Doxorubicin—TOP2A—Irinotecan—Topotecan—cervical cancer	0.000351	0.276	CbGdCrCtD
Doxorubicin—Blood bilirubin increased—Topotecan—cervical cancer	0.00035	0.0164	CcSEcCtD
Doxorubicin—AKR1A1—uterus—cervical cancer	0.00035	0.00859	CbGeAlD
Doxorubicin—Bone pain—Topotecan—cervical cancer	0.000346	0.0162	CcSEcCtD
Doxorubicin—AURKA—renal system—cervical cancer	0.000332	0.00815	CbGeAlD
Doxorubicin—Pulmonary embolism—Topotecan—cervical cancer	0.000331	0.0155	CcSEcCtD
Doxorubicin—NOS1—epithelium—cervical cancer	0.000321	0.00788	CbGeAlD
Doxorubicin—AURKA—endometrium—cervical cancer	0.000321	0.00788	CbGeAlD
Doxorubicin—Colitis—Topotecan—cervical cancer	0.000318	0.0149	CcSEcCtD
Doxorubicin—NDUFS2—uterine cervix—cervical cancer	0.000316	0.00777	CbGeAlD
Doxorubicin—AKR1A1—female reproductive system—cervical cancer	0.000314	0.00773	CbGeAlD
Doxorubicin—NDUFS3—uterine cervix—cervical cancer	0.000312	0.00767	CbGeAlD
Doxorubicin—Neuropathy—Topotecan—cervical cancer	0.000311	0.0146	CcSEcCtD
Doxorubicin—AURKA—mammalian vulva—cervical cancer	0.00031	0.00762	CbGeAlD
Doxorubicin—NDUFS2—decidua—cervical cancer	0.000301	0.0074	CbGeAlD
Doxorubicin—Rash maculo-papular—Topotecan—cervical cancer	0.000301	0.0141	CcSEcCtD
Doxorubicin—Neoplasm—Topotecan—cervical cancer	0.000299	0.014	CcSEcCtD
Doxorubicin—NOS1—renal system—cervical cancer	0.000297	0.00731	CbGeAlD
Doxorubicin—NDUFS3—decidua—cervical cancer	0.000297	0.00731	CbGeAlD
Doxorubicin—DHCR7—uterine cervix—cervical cancer	0.000297	0.00729	CbGeAlD
Doxorubicin—NDUFS2—renal system—cervical cancer	0.000296	0.00727	CbGeAlD
Doxorubicin—AURKA—uterus—cervical cancer	0.000295	0.00726	CbGeAlD
Doxorubicin—NDUFS3—renal system—cervical cancer	0.000292	0.00718	CbGeAlD
Doxorubicin—Sepsis—Topotecan—cervical cancer	0.000287	0.0135	CcSEcCtD
Doxorubicin—AKR1A1—female gonad—cervical cancer	0.000286	0.00703	CbGeAlD
Doxorubicin—NDUFS2—endometrium—cervical cancer	0.000286	0.00702	CbGeAlD
Doxorubicin—NDUFS7—female reproductive system—cervical cancer	0.000286	0.00702	CbGeAlD
Doxorubicin—AKR1A1—vagina—cervical cancer	0.000284	0.00699	CbGeAlD
Doxorubicin—NDUFS3—endometrium—cervical cancer	0.000282	0.00694	CbGeAlD
Doxorubicin—NDUFS2—mammalian vulva—cervical cancer	0.000276	0.00679	CbGeAlD
Doxorubicin—NDUFS3—mammalian vulva—cervical cancer	0.000273	0.00671	CbGeAlD
Doxorubicin—YWHAG—uterine cervix—cervical cancer	0.000272	0.00669	CbGeAlD
Doxorubicin—ABCC6—renal system—cervical cancer	0.00027	0.00664	CbGeAlD
Doxorubicin—AURKA—female reproductive system—cervical cancer	0.000266	0.00653	CbGeAlD
Doxorubicin—XDH—uterine cervix—cervical cancer	0.000265	0.00652	CbGeAlD
Doxorubicin—NDUFS2—uterus—cervical cancer	0.000263	0.00647	CbGeAlD
Doxorubicin—NDUFS3—uterus—cervical cancer	0.00026	0.00639	CbGeAlD
Doxorubicin—NDUFS7—female gonad—cervical cancer	0.00026	0.00639	CbGeAlD
Doxorubicin—DHCR7—mammalian vulva—cervical cancer	0.000259	0.00638	CbGeAlD
Doxorubicin—YWHAG—decidua—cervical cancer	0.000259	0.00637	CbGeAlD
Doxorubicin—NDUFS7—vagina—cervical cancer	0.000258	0.00635	CbGeAlD
Doxorubicin—YWHAG—renal system—cervical cancer	0.000255	0.00626	CbGeAlD
Doxorubicin—Dermatitis bullous—Topotecan—cervical cancer	0.000251	0.0118	CcSEcCtD
Doxorubicin—XDH—renal system—cervical cancer	0.000248	0.0061	CbGeAlD
Doxorubicin—Anaphylactoid reaction—Topotecan—cervical cancer	0.000248	0.0116	CcSEcCtD
Doxorubicin—ABCB8—lymph node—cervical cancer	0.000247	0.00608	CbGeAlD
Doxorubicin—YWHAG—endometrium—cervical cancer	0.000246	0.00605	CbGeAlD
Doxorubicin—RALBP1—uterine cervix—cervical cancer	0.000246	0.00604	CbGeAlD
Doxorubicin—Lethargy—Topotecan—cervical cancer	0.000245	0.0115	CcSEcCtD
Doxorubicin—NOS3—epithelium—cervical cancer	0.000244	0.00599	CbGeAlD
Doxorubicin—AURKA—female gonad—cervical cancer	0.000242	0.00594	CbGeAlD
Doxorubicin—AURKA—vagina—cervical cancer	0.00024	0.0059	CbGeAlD
Doxorubicin—XDH—endometrium—cervical cancer	0.00024	0.0059	CbGeAlD
Doxorubicin—NOS1—female reproductive system—cervical cancer	0.000238	0.00586	CbGeAlD
Doxorubicin—CBR3—lymph node—cervical cancer	0.000238	0.00585	CbGeAlD
Doxorubicin—YWHAG—mammalian vulva—cervical cancer	0.000238	0.00585	CbGeAlD
Doxorubicin—NDUFS2—female reproductive system—cervical cancer	0.000237	0.00582	CbGeAlD
Doxorubicin—RALBP1—decidua—cervical cancer	0.000234	0.00575	CbGeAlD
Doxorubicin—NDUFS3—female reproductive system—cervical cancer	0.000234	0.00575	CbGeAlD
Doxorubicin—XDH—mammalian vulva—cervical cancer	0.000232	0.00571	CbGeAlD
Doxorubicin—RALBP1—renal system—cervical cancer	0.00023	0.00565	CbGeAlD
Doxorubicin—CBR1—uterine cervix—cervical cancer	0.000229	0.00564	CbGeAlD
Doxorubicin—Cardiac arrest—Topotecan—cervical cancer	0.000228	0.0107	CcSEcCtD
Doxorubicin—YWHAG—uterus—cervical cancer	0.000227	0.00557	CbGeAlD
Doxorubicin—AKR1C3—uterine cervix—cervical cancer	0.000227	0.00557	CbGeAlD
Doxorubicin—NOS3—renal system—cervical cancer	0.000226	0.00556	CbGeAlD
Doxorubicin—RALBP1—endometrium—cervical cancer	0.000222	0.00546	CbGeAlD
Doxorubicin—DHCR7—female reproductive system—cervical cancer	0.000222	0.00546	CbGeAlD
Doxorubicin—CBR1—decidua—cervical cancer	0.000219	0.00537	CbGeAlD
Doxorubicin—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.000216	0.0102	CcSEcCtD
Doxorubicin—AKR1C3—decidua—cervical cancer	0.000216	0.00531	CbGeAlD
Doxorubicin—NDUFS2—female gonad—cervical cancer	0.000215	0.00529	CbGeAlD
Doxorubicin—RALBP1—mammalian vulva—cervical cancer	0.000215	0.00528	CbGeAlD
Doxorubicin—CBR1—renal system—cervical cancer	0.000215	0.00527	CbGeAlD
Doxorubicin—NDUFS2—vagina—cervical cancer	0.000214	0.00526	CbGeAlD
Doxorubicin—NDUFS3—female gonad—cervical cancer	0.000213	0.00523	CbGeAlD
Doxorubicin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000212	0.00994	CcSEcCtD
Doxorubicin—NDUFS3—vagina—cervical cancer	0.000212	0.0052	CbGeAlD
Doxorubicin—CBR1—endometrium—cervical cancer	0.000207	0.0051	CbGeAlD
Doxorubicin—POR—uterine cervix—cervical cancer	0.000207	0.00508	CbGeAlD
Doxorubicin—AKR1C3—endometrium—cervical cancer	0.000205	0.00504	CbGeAlD
Doxorubicin—RALBP1—uterus—cervical cancer	0.000205	0.00503	CbGeAlD
Doxorubicin—YWHAG—female reproductive system—cervical cancer	0.000204	0.00501	CbGeAlD
Doxorubicin—DHCR7—female gonad—cervical cancer	0.000202	0.00497	CbGeAlD
Doxorubicin—DHCR7—vagina—cervical cancer	0.000201	0.00494	CbGeAlD
Doxorubicin—CBR1—mammalian vulva—cervical cancer	0.000201	0.00493	CbGeAlD
Doxorubicin—XDH—female reproductive system—cervical cancer	0.000199	0.00489	CbGeAlD
Doxorubicin—AKR1C3—mammalian vulva—cervical cancer	0.000198	0.00487	CbGeAlD
Doxorubicin—Pancytopenia—Topotecan—cervical cancer	0.000197	0.00925	CcSEcCtD
Doxorubicin—POR—decidua—cervical cancer	0.000197	0.00484	CbGeAlD
Doxorubicin—Neutropenia—Topotecan—cervical cancer	0.000194	0.00911	CcSEcCtD
Doxorubicin—TOP2A—uterine cervix—cervical cancer	0.000193	0.00474	CbGeAlD
Doxorubicin—CBR1—uterus—cervical cancer	0.000191	0.0047	CbGeAlD
Doxorubicin—Weight increased—Topotecan—cervical cancer	0.000189	0.00887	CcSEcCtD
Doxorubicin—AKR1C3—uterus—cervical cancer	0.000189	0.00464	CbGeAlD
Doxorubicin—POR—endometrium—cervical cancer	0.000187	0.0046	CbGeAlD
Doxorubicin—Pneumonia—Topotecan—cervical cancer	0.000186	0.00874	CcSEcCtD
Doxorubicin—YWHAG—female gonad—cervical cancer	0.000186	0.00456	CbGeAlD
Doxorubicin—NQO1—epithelium—cervical cancer	0.000185	0.00456	CbGeAlD
Doxorubicin—Infestation—Topotecan—cervical cancer	0.000185	0.00869	CcSEcCtD
Doxorubicin—Infestation NOS—Topotecan—cervical cancer	0.000185	0.00869	CcSEcCtD
Doxorubicin—YWHAG—vagina—cervical cancer	0.000184	0.00453	CbGeAlD
Doxorubicin—RALBP1—female reproductive system—cervical cancer	0.000184	0.00452	CbGeAlD
Doxorubicin—AKR1A1—lymph node—cervical cancer	0.000184	0.00452	CbGeAlD
Doxorubicin—NQO1—uterine cervix—cervical cancer	0.000184	0.00452	CbGeAlD
Doxorubicin—TOP2A—decidua—cervical cancer	0.000184	0.00452	CbGeAlD
Doxorubicin—Neuropathy peripheral—Topotecan—cervical cancer	0.000181	0.00852	CcSEcCtD
Doxorubicin—NOS3—female reproductive system—cervical cancer	0.000181	0.00445	CbGeAlD
Doxorubicin—POR—mammalian vulva—cervical cancer	0.000181	0.00445	CbGeAlD
Doxorubicin—Stomatitis—Topotecan—cervical cancer	0.00018	0.00847	CcSEcCtD
Doxorubicin—XDH—vagina—cervical cancer	0.00018	0.00442	CbGeAlD
Doxorubicin—Sweating—Topotecan—cervical cancer	0.000178	0.00833	CcSEcCtD
Doxorubicin—NQO1—decidua—cervical cancer	0.000175	0.0043	CbGeAlD
Doxorubicin—Hepatobiliary disease—Topotecan—cervical cancer	0.000175	0.00822	CcSEcCtD
Doxorubicin—Epistaxis—Topotecan—cervical cancer	0.000175	0.00819	CcSEcCtD
Doxorubicin—TOP2A—endometrium—cervical cancer	0.000174	0.00429	CbGeAlD
Doxorubicin—NQO1—renal system—cervical cancer	0.000172	0.00423	CbGeAlD
Doxorubicin—CBR1—female reproductive system—cervical cancer	0.000172	0.00422	CbGeAlD
Doxorubicin—TOP2A—mammalian vulva—cervical cancer	0.000169	0.00415	CbGeAlD
Doxorubicin—RALBP1—female gonad—cervical cancer	0.000168	0.00412	CbGeAlD
Doxorubicin—NDUFS7—lymph node—cervical cancer	0.000167	0.00411	CbGeAlD
Doxorubicin—Haemoglobin—Topotecan—cervical cancer	0.000167	0.00784	CcSEcCtD
Doxorubicin—Rhinitis—Topotecan—cervical cancer	0.000167	0.00782	CcSEcCtD
Doxorubicin—RALBP1—vagina—cervical cancer	0.000167	0.00409	CbGeAlD
Doxorubicin—NQO1—endometrium—cervical cancer	0.000166	0.00409	CbGeAlD
Doxorubicin—Haemorrhage—Topotecan—cervical cancer	0.000166	0.0078	CcSEcCtD
Doxorubicin—Hypoaesthesia—Topotecan—cervical cancer	0.000165	0.00776	CcSEcCtD
Doxorubicin—Pharyngitis—Topotecan—cervical cancer	0.000165	0.00774	CcSEcCtD
Doxorubicin—ABCC10—uterine cervix—cervical cancer	0.000164	0.00403	CbGeAlD
Doxorubicin—NOS3—vagina—cervical cancer	0.000164	0.00403	CbGeAlD
Doxorubicin—NQO1—mammalian vulva—cervical cancer	0.000161	0.00395	CbGeAlD
Doxorubicin—TOP2A—uterus—cervical cancer	0.000161	0.00395	CbGeAlD
Doxorubicin—ABCC3—decidua—cervical cancer	0.000157	0.00386	CbGeAlD
Doxorubicin—ABCC10—decidua—cervical cancer	0.000156	0.00384	CbGeAlD
Doxorubicin—CBR1—female gonad—cervical cancer	0.000156	0.00384	CbGeAlD
Doxorubicin—CBR1—vagina—cervical cancer	0.000155	0.00382	CbGeAlD
Doxorubicin—AURKA—lymph node—cervical cancer	0.000155	0.00382	CbGeAlD
Doxorubicin—AKR1C3—female gonad—cervical cancer	0.000154	0.0038	CbGeAlD
Doxorubicin—ABCC3—renal system—cervical cancer	0.000154	0.00379	CbGeAlD
Doxorubicin—ABCC10—renal system—cervical cancer	0.000154	0.00377	CbGeAlD
Doxorubicin—AKR1C3—vagina—cervical cancer	0.000154	0.00377	CbGeAlD
Doxorubicin—NQO1—uterus—cervical cancer	0.000153	0.00376	CbGeAlD
Doxorubicin—Angiopathy—Topotecan—cervical cancer	0.000151	0.00708	CcSEcCtD
Doxorubicin—Immune system disorder—Topotecan—cervical cancer	0.00015	0.00704	CcSEcCtD
Doxorubicin—Mediastinal disorder—Topotecan—cervical cancer	0.00015	0.00703	CcSEcCtD
Doxorubicin—Chills—Topotecan—cervical cancer	0.000149	0.007	CcSEcCtD
Doxorubicin—ABCC10—endometrium—cervical cancer	0.000148	0.00365	CbGeAlD
Doxorubicin—Alopecia—Topotecan—cervical cancer	0.000147	0.00689	CcSEcCtD
Doxorubicin—Malnutrition—Topotecan—cervical cancer	0.000145	0.00679	CcSEcCtD
Doxorubicin—ABCC10—mammalian vulva—cervical cancer	0.000144	0.00353	CbGeAlD
Doxorubicin—POR—female gonad—cervical cancer	0.000141	0.00347	CbGeAlD
Doxorubicin—POR—vagina—cervical cancer	0.00014	0.00345	CbGeAlD
Doxorubicin—Back pain—Topotecan—cervical cancer	0.00014	0.00657	CcSEcCtD
Doxorubicin—Muscle spasms—Topotecan—cervical cancer	0.000139	0.00653	CcSEcCtD
Doxorubicin—NDUFS2—lymph node—cervical cancer	0.000138	0.0034	CbGeAlD
Doxorubicin—NQO1—female reproductive system—cervical cancer	0.000138	0.00338	CbGeAlD
Doxorubicin—ABCC10—uterus—cervical cancer	0.000137	0.00336	CbGeAlD
Doxorubicin—NDUFS3—lymph node—cervical cancer	0.000137	0.00336	CbGeAlD
Doxorubicin—Ill-defined disorder—Topotecan—cervical cancer	0.000134	0.0063	CcSEcCtD
Doxorubicin—Anaemia—Topotecan—cervical cancer	0.000134	0.00628	CcSEcCtD
Doxorubicin—TOP2A—female gonad—cervical cancer	0.000131	0.00323	CbGeAlD
Doxorubicin—TOP2A—vagina—cervical cancer	0.000131	0.00321	CbGeAlD
Doxorubicin—Malaise—Topotecan—cervical cancer	0.00013	0.00612	CcSEcCtD
Doxorubicin—DHCR7—lymph node—cervical cancer	0.00013	0.00319	CbGeAlD
Doxorubicin—Leukopenia—Topotecan—cervical cancer	0.00013	0.00608	CcSEcCtD
Doxorubicin—Cough—Topotecan—cervical cancer	0.000126	0.00592	CcSEcCtD
Doxorubicin—NQO1—female gonad—cervical cancer	0.000125	0.00308	CbGeAlD
Doxorubicin—NQO1—vagina—cervical cancer	0.000125	0.00306	CbGeAlD
Doxorubicin—ABCC3—female reproductive system—cervical cancer	0.000124	0.00304	CbGeAlD
Doxorubicin—ABCC2—renal system—cervical cancer	0.000123	0.00303	CbGeAlD
Doxorubicin—Arthralgia—Topotecan—cervical cancer	0.000123	0.00578	CcSEcCtD
Doxorubicin—Chest pain—Topotecan—cervical cancer	0.000123	0.00578	CcSEcCtD
Doxorubicin—Myalgia—Topotecan—cervical cancer	0.000123	0.00578	CcSEcCtD
Doxorubicin—ABCC10—female reproductive system—cervical cancer	0.000123	0.00302	CbGeAlD
Doxorubicin—CYP1B1—decidua—cervical cancer	0.000123	0.00302	CbGeAlD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000122	0.00574	CcSEcCtD
Doxorubicin—Discomfort—Topotecan—cervical cancer	0.000122	0.00571	CcSEcCtD
Doxorubicin—CYP1B1—renal system—cervical cancer	0.000121	0.00297	CbGeAlD
Doxorubicin—YWHAG—lymph node—cervical cancer	0.000119	0.00293	CbGeAlD
Doxorubicin—Anaphylactic shock—Topotecan—cervical cancer	0.000118	0.00554	CcSEcCtD
Doxorubicin—Infection—Topotecan—cervical cancer	0.000117	0.0055	CcSEcCtD
Doxorubicin—ABCC1—uterine cervix—cervical cancer	0.000116	0.00285	CbGeAlD
Doxorubicin—Nervous system disorder—Topotecan—cervical cancer	0.000116	0.00543	CcSEcCtD
Doxorubicin—Thrombocytopenia—Topotecan—cervical cancer	0.000116	0.00543	CcSEcCtD
Doxorubicin—Skin disorder—Topotecan—cervical cancer	0.000115	0.00538	CcSEcCtD
Doxorubicin—Hyperhidrosis—Topotecan—cervical cancer	0.000114	0.00536	CcSEcCtD
Doxorubicin—Anorexia—Topotecan—cervical cancer	0.000113	0.00528	CcSEcCtD
Doxorubicin—ABCC3—female gonad—cervical cancer	0.000112	0.00276	CbGeAlD
Doxorubicin—ABCC10—female gonad—cervical cancer	0.000112	0.00275	CbGeAlD
Doxorubicin—ABCC10—vagina—cervical cancer	0.000111	0.00273	CbGeAlD
Doxorubicin—ABCC1—decidua—cervical cancer	0.000111	0.00272	CbGeAlD
Doxorubicin—RALBP1—lymph node—cervical cancer	0.000108	0.00265	CbGeAlD
Doxorubicin—CYP1B1—uterus—cervical cancer	0.000108	0.00264	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000108	0.00505	CcSEcCtD
Doxorubicin—Paraesthesia—Topotecan—cervical cancer	0.000106	0.00498	CcSEcCtD
Doxorubicin—NOS3—lymph node—cervical cancer	0.000106	0.0026	CbGeAlD
Doxorubicin—Dyspnoea—Topotecan—cervical cancer	0.000105	0.00494	CcSEcCtD
Doxorubicin—ABCC1—endometrium—cervical cancer	0.000105	0.00258	CbGeAlD
Doxorubicin—Dyspepsia—Topotecan—cervical cancer	0.000104	0.00488	CcSEcCtD
Doxorubicin—Decreased appetite—Topotecan—cervical cancer	0.000103	0.00482	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Topotecan—cervical cancer	0.000102	0.00478	CcSEcCtD
Doxorubicin—Fatigue—Topotecan—cervical cancer	0.000102	0.00478	CcSEcCtD
Doxorubicin—ABCC1—mammalian vulva—cervical cancer	0.000102	0.0025	CbGeAlD
Doxorubicin—Constipation—Topotecan—cervical cancer	0.000101	0.00474	CcSEcCtD
Doxorubicin—Pain—Topotecan—cervical cancer	0.000101	0.00474	CcSEcCtD
Doxorubicin—CBR1—lymph node—cervical cancer	0.000101	0.00247	CbGeAlD
Doxorubicin—AKR1C3—lymph node—cervical cancer	9.93e-05	0.00244	CbGeAlD
Doxorubicin—ABCC2—female reproductive system—cervical cancer	9.88e-05	0.00243	CbGeAlD
Doxorubicin—Feeling abnormal—Topotecan—cervical cancer	9.73e-05	0.00457	CcSEcCtD
Doxorubicin—ABCC1—uterus—cervical cancer	9.68e-05	0.00238	CbGeAlD
Doxorubicin—CYP1B1—female reproductive system—cervical cancer	9.67e-05	0.00238	CbGeAlD
Doxorubicin—Gastrointestinal pain—Topotecan—cervical cancer	9.66e-05	0.00453	CcSEcCtD
Doxorubicin—ABCG2—uterine cervix—cervical cancer	9.61e-05	0.00236	CbGeAlD
Doxorubicin—Urticaria—Topotecan—cervical cancer	9.38e-05	0.0044	CcSEcCtD
Doxorubicin—Body temperature increased—Topotecan—cervical cancer	9.34e-05	0.00438	CcSEcCtD
Doxorubicin—Abdominal pain—Topotecan—cervical cancer	9.34e-05	0.00438	CcSEcCtD
Doxorubicin—ABCG2—decidua—cervical cancer	9.16e-05	0.00225	CbGeAlD
Doxorubicin—POR—lymph node—cervical cancer	9.07e-05	0.00223	CbGeAlD
Doxorubicin—CYP1B1—female gonad—cervical cancer	8.8e-05	0.00216	CbGeAlD
Doxorubicin—Hypersensitivity—Topotecan—cervical cancer	8.7e-05	0.00408	CcSEcCtD
Doxorubicin—ABCG2—endometrium—cervical cancer	8.69e-05	0.00214	CbGeAlD
Doxorubicin—Asthenia—Topotecan—cervical cancer	8.47e-05	0.00398	CcSEcCtD
Doxorubicin—TOP2A—lymph node—cervical cancer	8.45e-05	0.00208	CbGeAlD
Doxorubicin—ABCG2—mammalian vulva—cervical cancer	8.41e-05	0.00207	CbGeAlD
Doxorubicin—Pruritus—Topotecan—cervical cancer	8.35e-05	0.00392	CcSEcCtD
Doxorubicin—CYP2B6—renal system—cervical cancer	8.3e-05	0.00204	CbGeAlD
Doxorubicin—Diarrhoea—Topotecan—cervical cancer	8.08e-05	0.00379	CcSEcCtD
Doxorubicin—NQO1—lymph node—cervical cancer	8.06e-05	0.00198	CbGeAlD
Doxorubicin—ABCG2—uterus—cervical cancer	8.01e-05	0.00197	CbGeAlD
Doxorubicin—ABCC1—female gonad—cervical cancer	7.92e-05	0.00195	CbGeAlD
Doxorubicin—ABCC1—vagina—cervical cancer	7.87e-05	0.00193	CbGeAlD
Doxorubicin—Dizziness—Topotecan—cervical cancer	7.81e-05	0.00366	CcSEcCtD
Doxorubicin—Vomiting—Topotecan—cervical cancer	7.51e-05	0.00352	CcSEcCtD
Doxorubicin—Rash—Topotecan—cervical cancer	7.45e-05	0.00349	CcSEcCtD
Doxorubicin—Dermatitis—Topotecan—cervical cancer	7.44e-05	0.00349	CcSEcCtD
Doxorubicin—Headache—Topotecan—cervical cancer	7.4e-05	0.00347	CcSEcCtD
Doxorubicin—ABCC3—lymph node—cervical cancer	7.23e-05	0.00178	CbGeAlD
Doxorubicin—ABCC10—lymph node—cervical cancer	7.2e-05	0.00177	CbGeAlD
Doxorubicin—Nausea—Topotecan—cervical cancer	7.01e-05	0.00329	CcSEcCtD
Doxorubicin—CYP2B6—female reproductive system—cervical cancer	6.64e-05	0.00163	CbGeAlD
Doxorubicin—ABCG2—female gonad—cervical cancer	6.55e-05	0.00161	CbGeAlD
Doxorubicin—ABCG2—vagina—cervical cancer	6.51e-05	0.0016	CbGeAlD
Doxorubicin—CYP3A4—renal system—cervical cancer	6.26e-05	0.00154	CbGeAlD
Doxorubicin—CYP2D6—renal system—cervical cancer	6.16e-05	0.00151	CbGeAlD
Doxorubicin—CYP2B6—vagina—cervical cancer	6.01e-05	0.00148	CbGeAlD
Doxorubicin—ABCC2—lymph node—cervical cancer	5.78e-05	0.00142	CbGeAlD
Doxorubicin—NOS3—Hemostasis—GP5—cervical cancer	5.77e-05	0.00533	CbGpPWpGaD
Doxorubicin—CYP1B1—lymph node—cervical cancer	5.66e-05	0.00139	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	5.6e-05	0.00517	CbGpPWpGaD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	5.42e-05	0.005	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—MTOR—cervical cancer	5.41e-05	0.00499	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	5.26e-05	0.00486	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—CASP8—cervical cancer	5.22e-05	0.00482	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	5.16e-05	0.00476	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	5.09e-05	0.0047	CbGpPWpGaD
Doxorubicin—NOS2—AGE/RAGE pathway—CASP3—cervical cancer	5.09e-05	0.0047	CbGpPWpGaD
Doxorubicin—ABCC1—lymph node—cervical cancer	5.09e-05	0.00125	CbGeAlD
Doxorubicin—CYP3A4—female reproductive system—cervical cancer	5.02e-05	0.00123	CbGeAlD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—cervical cancer	4.96e-05	0.00458	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	4.94e-05	0.00456	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	4.94e-05	0.00456	CbGpPWpGaD
Doxorubicin—CYP2D6—female reproductive system—cervical cancer	4.94e-05	0.00121	CbGeAlD
Doxorubicin—TOP2A—Gastric Cancer Network 2—EGFR—cervical cancer	4.86e-05	0.00449	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	4.85e-05	0.00448	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HES1—cervical cancer	4.81e-05	0.00444	CbGpPWpGaD
Doxorubicin—ABCB1—epithelium—cervical cancer	4.78e-05	0.00117	CbGeAlD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	4.77e-05	0.0044	CbGpPWpGaD
Doxorubicin—ABCB1—uterine cervix—cervical cancer	4.74e-05	0.00116	CbGeAlD
Doxorubicin—NOS2—IL12-mediated signaling events—STAT3—cervical cancer	4.62e-05	0.00426	CbGpPWpGaD
Doxorubicin—ABCB1—decidua—cervical cancer	4.52e-05	0.00111	CbGeAlD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—cervical cancer	4.49e-05	0.00415	CbGpPWpGaD
Doxorubicin—CYP2D6—female gonad—cervical cancer	4.49e-05	0.0011	CbGeAlD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	4.48e-05	0.00413	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—CASP8—cervical cancer	4.48e-05	0.00413	CbGpPWpGaD
Doxorubicin—ABCB1—renal system—cervical cancer	4.43e-05	0.00109	CbGeAlD
Doxorubicin—ABCB1—endometrium—cervical cancer	4.29e-05	0.00105	CbGeAlD
Doxorubicin—NOS2—AGE/RAGE pathway—STAT3—cervical cancer	4.28e-05	0.00395	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	4.28e-05	0.00395	CbGpPWpGaD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	4.25e-05	0.00392	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—CASP3—cervical cancer	4.24e-05	0.00391	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	4.23e-05	0.0039	CbGpPWpGaD
Doxorubicin—ABCG2—lymph node—cervical cancer	4.21e-05	0.00104	CbGeAlD
Doxorubicin—ABCB1—mammalian vulva—cervical cancer	4.15e-05	0.00102	CbGeAlD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	4.11e-05	0.0038	CbGpPWpGaD
Doxorubicin—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	4.09e-05	0.00378	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—cervical cancer	4.08e-05	0.00377	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—CASP3—cervical cancer	3.95e-05	0.00365	CbGpPWpGaD
Doxorubicin—ABCB1—uterus—cervical cancer	3.95e-05	0.000971	CbGeAlD
Doxorubicin—NOS2—AGE/RAGE pathway—EGFR—cervical cancer	3.89e-05	0.00359	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—MTOR—cervical cancer	3.88e-05	0.00358	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	3.84e-05	0.00355	CbGpPWpGaD
Doxorubicin—NOS1—Alzheimers Disease—TP53—cervical cancer	3.75e-05	0.00346	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—MTOR—cervical cancer	3.73e-05	0.00344	CbGpPWpGaD
Doxorubicin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	3.72e-05	0.00343	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CA9—cervical cancer	3.68e-05	0.0034	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CA9—cervical cancer	3.68e-05	0.0034	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—MTOR—cervical cancer	3.68e-05	0.0034	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	3.57e-05	0.00329	CbGpPWpGaD
Doxorubicin—ABCB1—female reproductive system—cervical cancer	3.55e-05	0.000873	CbGeAlD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	3.48e-05	0.00321	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CA9—cervical cancer	3.46e-05	0.0032	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	3.46e-05	0.00319	CbGpPWpGaD
Doxorubicin—NOS3—Thromboxane A2 receptor signaling—EGFR—cervical cancer	3.44e-05	0.00318	CbGpPWpGaD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—cervical cancer	3.43e-05	0.00317	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—CASP3—cervical cancer	3.39e-05	0.00313	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—EGFR—cervical cancer	3.35e-05	0.00309	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—STAT3—cervical cancer	3.32e-05	0.00307	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—CASP8—cervical cancer	3.32e-05	0.00307	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	3.26e-05	0.00301	CbGpPWpGaD
Doxorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	3.26e-05	0.00301	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—EGFR—cervical cancer	3.24e-05	0.00299	CbGpPWpGaD
Doxorubicin—ABCB1—female gonad—cervical cancer	3.23e-05	0.000794	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	3.23e-05	0.00298	CbGpPWpGaD
Doxorubicin—ABCB1—vagina—cervical cancer	3.21e-05	0.000789	CbGeAlD
Doxorubicin—NOS2—Spinal Cord Injury—CASP3—cervical cancer	3.2e-05	0.00295	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TAAR6—cervical cancer	3.17e-05	0.00292	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	3.14e-05	0.0029	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—CASP3—cervical cancer	3.03e-05	0.0028	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—EGFR—cervical cancer	3.02e-05	0.00279	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—STAT3—cervical cancer	3e-05	0.00277	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CA9—cervical cancer	2.95e-05	0.00272	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—CTNNB1—cervical cancer	2.92e-05	0.0027	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	2.92e-05	0.0027	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—STAT3—cervical cancer	2.88e-05	0.00266	CbGpPWpGaD
Doxorubicin—NOS1—Disease—WNT2—cervical cancer	2.82e-05	0.00261	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—MTOR—cervical cancer	2.76e-05	0.00254	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CA9—cervical cancer	2.75e-05	0.00254	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—cervical cancer	2.72e-05	0.00251	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	2.69e-05	0.00248	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—EGFR—cervical cancer	2.62e-05	0.00242	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	2.59e-05	0.00239	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—cervical cancer	2.59e-05	0.00239	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	2.57e-05	0.00237	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—CASP3—cervical cancer	2.51e-05	0.00232	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—cervical cancer	2.51e-05	0.00232	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—cervical cancer	2.5e-05	0.00231	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—WNT2—cervical cancer	2.47e-05	0.00228	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	2.44e-05	0.00226	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—CTNNB1—cervical cancer	2.44e-05	0.00226	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—EGFR—cervical cancer	2.44e-05	0.00225	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—CTNNB1—cervical cancer	2.42e-05	0.00224	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	2.41e-05	0.00222	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	2.37e-05	0.00219	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	2.37e-05	0.00219	CbGpPWpGaD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	2.37e-05	0.00218	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—cervical cancer	2.25e-05	0.00208	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—cervical cancer	2.17e-05	0.002	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKAP13—cervical cancer	2.17e-05	0.002	CbGpPWpGaD
Doxorubicin—NOS1—Disease—WNT5A—cervical cancer	2.14e-05	0.00197	CbGpPWpGaD
Doxorubicin—NOS2—Disease—WNT2—cervical cancer	2.13e-05	0.00197	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	2.1e-05	0.00193	CbGpPWpGaD
Doxorubicin—ABCB1—lymph node—cervical cancer	2.08e-05	0.000511	CbGeAlD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—cervical cancer	2.05e-05	0.00189	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TERT—cervical cancer	2.05e-05	0.00189	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	2.01e-05	0.00185	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.97e-05	0.00181	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—WNT2—cervical cancer	1.96e-05	0.00181	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	1.93e-05	0.00178	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—WNT5A—cervical cancer	1.87e-05	0.00173	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	1.79e-05	0.00165	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TAAR6—cervical cancer	1.76e-05	0.00162	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	1.73e-05	0.0016	CbGpPWpGaD
Doxorubicin—NOS3—Disease—WNT2—cervical cancer	1.65e-05	0.00153	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	1.62e-05	0.00149	CbGpPWpGaD
Doxorubicin—NOS2—Disease—WNT5A—cervical cancer	1.61e-05	0.00149	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TP53—cervical cancer	1.61e-05	0.00149	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CA9—cervical cancer	1.6e-05	0.00148	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TERT—cervical cancer	1.55e-05	0.00143	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CA9—cervical cancer	1.55e-05	0.00143	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—MTHFR—cervical cancer	1.5e-05	0.00138	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—MTHFR—cervical cancer	1.5e-05	0.00138	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.49e-05	0.00137	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TAAR6—cervical cancer	1.48e-05	0.00137	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—WNT5A—cervical cancer	1.48e-05	0.00137	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	1.47e-05	0.00136	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CA9—cervical cancer	1.44e-05	0.00133	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.43e-05	0.00132	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—MTHFR—cervical cancer	1.41e-05	0.0013	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—WNT2—cervical cancer	1.37e-05	0.00126	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—cervical cancer	1.34e-05	0.00124	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOTCH2—cervical cancer	1.32e-05	0.00121	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CASP8—cervical cancer	1.31e-05	0.00121	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CA9—cervical cancer	1.31e-05	0.00121	CbGpPWpGaD
Doxorubicin—NOS3—Disease—WNT5A—cervical cancer	1.25e-05	0.00116	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HES1—cervical cancer	1.23e-05	0.00114	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKAP13—cervical cancer	1.2e-05	0.00111	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—MTHFR—cervical cancer	1.2e-05	0.0011	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—WNT2—cervical cancer	1.16e-05	0.00107	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.14e-05	0.00105	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—MTHFR—cervical cancer	1.11e-05	0.00103	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TERT—cervical cancer	1.08e-05	0.001	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MTHFR—cervical cancer	1.08e-05	0.000998	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TERT—cervical cancer	1.08e-05	0.000996	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HES1—cervical cancer	1.08e-05	0.000995	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CA9—cervical cancer	1.06e-05	0.000979	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—WNT5A—cervical cancer	1.04e-05	0.000958	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CA9—cervical cancer	1.02e-05	0.000939	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKAP13—cervical cancer	1.02e-05	0.000938	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—WNT2—cervical cancer	1.01e-05	0.00093	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CASP3—cervical cancer	9.92e-06	0.000916	CbGpPWpGaD
Doxorubicin—NOS1—Disease—FGFR3—cervical cancer	9.9e-06	0.000914	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	9.54e-06	0.00088	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TERT—cervical cancer	9.45e-06	0.000872	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOTCH1—cervical cancer	9.29e-06	0.000858	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HES1—cervical cancer	9.29e-06	0.000857	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—cervical cancer	9.16e-06	0.000845	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—WNT5A—cervical cancer	8.77e-06	0.00081	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FGFR3—cervical cancer	8.67e-06	0.0008	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HES1—cervical cancer	8.53e-06	0.000788	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—cervical cancer	8.48e-06	0.000783	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MTHFR—cervical cancer	8.16e-06	0.000753	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOTCH1—cervical cancer	8.14e-06	0.000751	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TERT—cervical cancer	8.14e-06	0.000751	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CA9—cervical cancer	7.97e-06	0.000735	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—cervical cancer	7.79e-06	0.000719	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CA9—cervical cancer	7.71e-06	0.000711	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—WNT5A—cervical cancer	7.63e-06	0.000705	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MTHFR—cervical cancer	7.5e-06	0.000692	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TERT—cervical cancer	7.48e-06	0.00069	CbGpPWpGaD
Doxorubicin—NOS2—Disease—FGFR3—cervical cancer	7.47e-06	0.000689	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH2—cervical cancer	7.29e-06	0.000673	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HES1—cervical cancer	7.21e-06	0.000666	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CA9—cervical cancer	7.01e-06	0.000647	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOTCH1—cervical cancer	7.01e-06	0.000647	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MTOR—cervical cancer	6.96e-06	0.000643	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—cervical cancer	6.95e-06	0.000642	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—FGFR3—cervical cancer	6.86e-06	0.000633	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTHFR—cervical cancer	6.51e-06	0.000601	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	6.47e-06	0.000597	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOTCH1—cervical cancer	6.44e-06	0.000595	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—cervical cancer	6.4e-06	0.000591	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTHFR—cervical cancer	6.34e-06	0.000585	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TERT—cervical cancer	6.32e-06	0.000583	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—cervical cancer	6.28e-06	0.00058	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CTNNB1—cervical cancer	6.17e-06	0.00057	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH2—cervical cancer	6.16e-06	0.000568	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MTOR—cervical cancer	6.1e-06	0.000563	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HES1—cervical cancer	5.98e-06	0.000552	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—cervical cancer	5.9e-06	0.000545	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—cervical cancer	5.84e-06	0.000539	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FGFR3—cervical cancer	5.8e-06	0.000535	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CASP3—cervical cancer	5.61e-06	0.000518	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOTCH1—cervical cancer	5.44e-06	0.000502	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CTNNB1—cervical cancer	5.41e-06	0.000499	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—cervical cancer	5.38e-06	0.000497	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—cervical cancer	5.31e-06	0.00049	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MTOR—cervical cancer	5.25e-06	0.000485	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—cervical cancer	5.24e-06	0.000484	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TERT—cervical cancer	5.24e-06	0.000483	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CA9—cervical cancer	5.14e-06	0.000474	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HES1—cervical cancer	5.05e-06	0.000466	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—cervical cancer	4.97e-06	0.000459	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.9e-06	0.000452	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—cervical cancer	4.89e-06	0.000452	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MTOR—cervical cancer	4.83e-06	0.000446	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—cervical cancer	4.82e-06	0.000445	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGFR3—cervical cancer	4.8e-06	0.000444	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.72e-06	0.000436	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—cervical cancer	4.71e-06	0.000435	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CTNNB1—cervical cancer	4.66e-06	0.00043	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH1—cervical cancer	4.51e-06	0.000416	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TERT—cervical cancer	4.42e-06	0.000408	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HES1—cervical cancer	4.39e-06	0.000406	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—cervical cancer	4.3e-06	0.000397	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—cervical cancer	4.28e-06	0.000396	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—cervical cancer	4.28e-06	0.000395	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—cervical cancer	4.13e-06	0.000381	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—cervical cancer	4.13e-06	0.000381	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTOR—cervical cancer	4.08e-06	0.000376	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—cervical cancer	4.07e-06	0.000376	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGFR3—cervical cancer	4.06e-06	0.000375	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—cervical cancer	4.06e-06	0.000375	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—cervical cancer	3.86e-06	0.000356	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TERT—cervical cancer	3.85e-06	0.000355	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH1—cervical cancer	3.81e-06	0.000352	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CA9—cervical cancer	3.79e-06	0.00035	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.74e-06	0.000345	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—cervical cancer	3.73e-06	0.000344	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—cervical cancer	3.69e-06	0.000341	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—cervical cancer	3.62e-06	0.000334	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—cervical cancer	3.6e-06	0.000332	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CA9—cervical cancer	3.57e-06	0.00033	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGFR3—cervical cancer	3.53e-06	0.000326	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—cervical cancer	3.39e-06	0.000313	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MTOR—cervical cancer	3.38e-06	0.000312	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOTCH1—cervical cancer	3.32e-06	0.000306	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—cervical cancer	3.23e-06	0.000298	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—cervical cancer	3.15e-06	0.000291	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.14e-06	0.00029	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—cervical cancer	3.13e-06	0.000289	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—cervical cancer	3.11e-06	0.000287	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—cervical cancer	3e-06	0.000277	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—cervical cancer	2.86e-06	0.000264	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MTOR—cervical cancer	2.86e-06	0.000264	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—cervical cancer	2.84e-06	0.000263	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—cervical cancer	2.63e-06	0.000242	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—cervical cancer	2.61e-06	0.000241	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—cervical cancer	2.53e-06	0.000234	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—cervical cancer	2.49e-06	0.000229	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—cervical cancer	2.48e-06	0.000229	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—cervical cancer	2.37e-06	0.000219	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA9—cervical cancer	2.34e-06	0.000216	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—cervical cancer	2.21e-06	0.000204	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—cervical cancer	2.2e-06	0.000203	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—cervical cancer	2.09e-06	0.000192	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—cervical cancer	2.01e-06	0.000185	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—cervical cancer	1.99e-06	0.000184	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—cervical cancer	1.92e-06	0.000177	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—cervical cancer	1.75e-06	0.000161	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—cervical cancer	1.68e-06	0.000155	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—cervical cancer	1.54e-06	0.000142	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—cervical cancer	1.45e-06	0.000134	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—cervical cancer	9.48e-07	8.75e-05	CbGpPWpGaD
